Abstract OBJECTIVE: To investigate the resistance of Helicobacter pylori (H.pylori) to antimicrobial agents in adolescents. METHODS: One hundred and eight adolescents (6-18 years old) underwent a gastroscopy examination. H.pylori strains were isolated from gastric mucosa. Antimicrobial susceptibility testing was performed by means of Kirby-Baner. RESULTS: Thirty-six H.pylori strains were identified. The resistant rate of H.pylori strains to clarithromycin, fruranzolidone and amoxicillin was 8.3%, 16.7% and 33.3%, respectively. H.pylori strains showed a high resistance to metronidazole (94.4%), while no strain was resistant to gentamicin and levofloxacin. CONCLUSIONS:The H.pylori strains from the adolescents in Zhejiang showed a high resistance to metronidazole and amoxicillin but a low resistance to clarithromycin and fruranzolidone. All of H.pylori strains were susceptive to gentamicin and levofloxacin.[Chin J Contemp Pediatr, 2009, 11 (3):210-212]
[5]Bazzoli F, Pozzato P. Therapy of H.pylori infection[J]. J Physiol Pharmacol, 1997, 48 (4 Suppl):39-46.
[6]Graham DY, Lew GM, Malaty HM, Evans DG, Evans DJ Jr, Klein PD, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy[J].Gastroenterology, 1992, 102(2):493-496.
[7]Peitz U, Sulliga M, Wolle K, Leodolter A, Von Arnim U, Kahl S, et al. High rate of post-therapeutic resistance after failure of macrolide-nitromidazole triple therapy to cure Helicobacter pylori infection:impact of two second-line therapies in a randomized study[J]. Aliment Pharmacol Ther, 2002, 16(2):315-324.
[8]Dzierzanowska-Fangrat K, Rozynek E, Józwiak P, Celińska-Cedro D, Madalinski K, Dzierzano-wska D. Primary resistance to Clarithromycin inclinical strains of Helicobacter pylori isolated from children in Poland[J]. Int J Antimicrob Agents, 2001, 18(4):387-390.
[9]Boyanova L, Gergova G, Nikolov R, Davidkov L, Kamburov V, Jelev C, et al. Prevalence and evolution of Helicobacter pylori resistance to 6 antibacterial agents over 12 years and correlation between susceptibility testing methods[J]. Diagn Microbiol Infect Dis, 2008, 60(4):409-415.
[10]Boyanova L, Stancheva I, Spassova Z, Katzarov N, Mitov I, Koumanova R. Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia,Bulgaria[J]. J Med Microbiol, 2000, 49(5):415-418.
[13]DiCaro S, Zocco MA, Cremonini F, Candelli M, Nista EC, Bartolozzi F, et al. Levofloxacin based regimens for the eradication of Helicobacter pylori[J]. Eur J Gastroenterol Hepatol, 2002, 14(12):1309-1312.
[14]Versalovic J, Shortridge D, Kibler K, Griffy MV, Beyer J, Flamm RK, et al. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori[J]. Antimicrob Agents Chemother, 1996, 40(2):477-480.